• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, October 20, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

PBMC CXCL8 expression associated with coronary artery disease in 250-person case-control study

by
October 20, 2026
in Biology
Reading Time: 2 mins read
0
PBMC CXCL8 expression associated with coronary artery disease in 250-person case-control study

Immune Cell Gene CXCL8 Emerges as Powerful Inflammatory Signal in Coronary Artery Disease

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In a case-control study summarized in the article abstract, expression of the inflammatory gene CXCL8 in peripheral blood mononuclear cells was significantly higher in 125 patients with angiographically confirmed coronary artery disease than in 125 healthy controls. The observed fold change was 1.94 (p < 0.001), while increased expression of IRAK1, TRAF6 and MAPK1 did not reach statistical significance.

Researchers compared the relative expression levels of four genes in the IL-1R/TLR pathway using peripheral blood mononuclear cells from the two groups. Group differences were evaluated with t-tests, and the researchers also conducted receiver operating characteristic curve analysis and multivariable binary logistic regression using z-scored ΔCt values for IRAK1, TRAF6, MAPK1 and CXCL8.

CXCL8 was the only gene whose association with coronary artery disease remained significant in the multivariable analysis (p < 0.001). In the reported receiver operating characteristic analysis, CXCL8 expression had an area under the curve of 0.81, which the abstract describes as good discrimination between patients and healthy controls. The abstract does not provide sensitivity, specificity, confidence intervals, validation results or evidence that the measure can diagnose individual patients in clinical practice.

A protein-protein interaction network analysis indicated that IRAK1, TRAF6 and MAPK1 formed an integrated upstream signalling module, whereas CXCL8 was positioned as a downstream inflammatory mediator. This computational interpretation supports a possible biological model for CXCL8 induction but does not establish a causal pathway or a clinical benefit. Because the available source is an abstract and includes no external validation, the reported discrimination and the proposed marker role remain findings of this case-control study rather than established diagnostic performance.

Subject of Research: Peripheral immune-cell CXCL8 expression as an inflammatory marker associated with coronary artery disease

Article Title: Peripheral immune cell expression of IRAK1, TRAF6, MAPK1 and CXCL8 in coronary artery disease

Article References: Subramanian, V., Kumar, M. J., Muralidharan, T. R., & Venkatesan, V. (2026). Peripheral immune cell expression of IRAK1, TRAF6, MAPK1 and CXCL8 in coronary artery disease. Molecular Biology Reports, 53(1), Article 1592. https://doi.org/10.1007/s11033-026-12710-0

Image Credits: AI Generated

DOI: 10.1007/s11033-026-12710-0

Keywords: coronary artery disease, CXCL8, peripheral blood mononuclear cells, case-control study, gene expression, inflammation, diagnostic discrimination, ROC analysis, IRAK1, TRAF6, MAPK1, Peripheral

News Source: Juliet Wilcox. (October 20, 2026). PBMC CXCL8 expression associated with coronary artery disease in 250-person case-control study. Scienmag.

Tags: case-control studyCoronary artery diseaseCXCL8diagnostic discriminationgene expressioninflammationIRAK1MAPK1peripheralperipheral blood mononuclear cellsROC analysisTRAF6
Share12Tweet7Share2ShareShareShare1

Related Posts

Deep-Gulf life remains depleted 16 years after oil spill

Deep-Gulf life remains depleted 16 years after oil spill

October 20, 2026
NHSL3 knockout alters sorafenib response, growth, and motility in two hepatocellular carcinoma cell models

NHSL3 knockout alters sorafenib response, growth, and motility in two hepatocellular carcinoma cell models

October 20, 2026

Sevoflurane reduced myocardial injury in rat and cell ischemia-reperfusion models through a circ_SMG6-related pathway

October 20, 2026

Mouse study finds SRS67 and SRS20A antibodies inhibit Toxoplasma gondii

October 20, 2026

POPULAR NEWS

  • Trinuclear palladium complex reduces chitosan’s optical band gap in experimental composite study

    Trinuclear palladium complex reduces chitosan’s optical band gap in experimental composite study

    29 shares
    Share 12 Tweet 7
  • Stem cell therapies improve tendon-bone healing in ACL animal models

    29 shares
    Share 12 Tweet 7
  • PBMC CXCL8 expression associated with coronary artery disease in 250-person case-control study

    29 shares
    Share 12 Tweet 7
  • Deep-Gulf life remains depleted 16 years after oil spill

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Trinuclear palladium complex reduces chitosan’s optical band gap in experimental composite study

Stem cell therapies improve tendon-bone healing in ACL animal models

PBMC CXCL8 expression associated with coronary artery disease in 250-person case-control study

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.